You can still find small-cap superstars
Small-cap superstars still abound

There are some picks in this sector that have excellent valuations and strong earnings growth.

VIDEO ON MSN MONEY

The medical device company tackles spinal cord injury with multiple technologies.

By TheStockAdvisors Jan 9, 2012 3:03PM
Image: Medical doctor (© image100/Corbis)This post is one in a series in which over 50 newsletter advisors share their Top Picks for 2012.

By Tom Bishop, BI Research

The financial impact of spinal cord injury (SCI) is staggering, estimated at between $244,000 and $829,000 in the first year alone. Over a lifetime the costs could add up to $1 to $4 million.  
Tags: NVIV

The irony surrounding the Atlanta skyscraper is pretty tall, even if the company doesn't own it.

By InvestorPlace Jan 9, 2012 2:55PM
Atlanta’s Bank of America Plaza is one of the 10 tallest structures in the U.S. And thanks to troubles at its namesake Bank of America Corp. (BAC) and other tenants, the skyscraper could be one of the tallest foreclosure tales of the financial crisis.

News came out recently that the company that owns the office building is struggling to meet its debt service as offices remain empty and the real estate crash continues to take a toll. 

With stricter environmental regulations in the U.S. and signs of a slowdown in China, coal's importance to freight carriers will likely decline.

By Trefis Jan 9, 2012 2:47PM
 Image: Coal miners (© Digital Vision/SuperStock)For years coal has been the commodity most transported by railroads, accounting for more than 40% of total carloads originating in the U.S. in the third quarter of this year.

While coal production and demand are likely to grow over the next few years, driving traffic volume for freight carriers such as CSX Corporation (CSX) and Union Pacific (UNP), there may be a long-term shift away from this reliance.  
Tags: csxUNP

Bullish chart patterns and relative performance analysis make these stocks worth buying on dips.

By MoneyShow.com Jan 9, 2012 2:23PM

By Tom Aspray, MoneyShow.com


As noted on Friday, the daily analysis of the PowerShares QQQ Trust (QQQ) shows that it has now started to outperform the S&P 500.


In my weekly Starc band analysis of the Nasdaq 100 stocks, I wanted to concentrate not only on those that were the closest to their weekly Starc+ or Starc- bands, but also on how these stocks had performed against the major averages since October.

 

New models from Ford and GM won't affect investors' views. The market cares only about sales.

By Jim Cramer Jan 9, 2012 1:55PM

Image: Salesman talking to woman in automobile showroom © Adam Gault/OJO Images/Getty ImagesBy Jim Cramer

 

We got news of new cars galore Monday. We heared about midsize cars from the Big Three that could challenge the Japanese, cars with technology that appeals to youths, cars that show off U.S. craftsmanship in a way that makes the Japanese seem, well, equal to -- not better than -- Ford  (F), GM (GM) or Chrysler.

 

If only it mattered to the stocks. First, we don't care about Chrysler unless we are trying to buy one. The idea of buying a European car company because of a strong Chrysler showing is pretty fanciful. Fiat is good. So what?

 

Even after a huge rally in 2011, this stock still has a full tank of gas.

By TheStockAdvisors Jan 9, 2012 1:54PM
Image: Natural gas (© Ron Chapple/Jupiterimages)This post is one in a series in which over 50 newsletter advisors share their Top Picks for 2012.

 By Nathan Slaughter, Energy & Income

Golar LNG (GLNG) shareholders will have fond memories of 2011 -- the stock delivered an impressive 196% return for the year. But the rally isn't over yet, because the same tailwinds behind it will continue blowing through at least 2014.  
Tags: GLNG

These stocks are in the sweet spot for continuing their winning ways into this year and beyond.

By MoneyShow.com Jan 9, 2012 1:38PM

Image: Stock market (© Digital Vision/SuperStock)By Richard Moroney, Upside

Special to MoneyShow.com


Cascade (CASC): The leading maker of material handling equipment in North America, this company is highly leveraged to demand for forklifts. Its primary end markets include pulp and paper, grocery products, textiles, and consumer goods. Cascade has rallied 12% since announcing impressive October quarter results on Dec. 1.


Per-share earnings were $1.74, up from 79 cents and handily above the consensus of $1.20. Results reflect lower interest expense, a favorable tax rate, and improved gross profit margins. Total revenue increased 29% to $138 million and beat the consensus by $5 million. Sales have topped expectations in five of the last six quarters.

 

The payoff for CEO Reed Hastings' international push may take a long time.

By Jonathan Berr Jan 9, 2012 1:24PM
Image: Europe (© Photodisc/SuperStock)Netflix (NFLX) CEO Reed Hastings, whose blunders in 2011 will be dissected in business schools for generations to come, may be laying the groundwork for another whopper with his expansion into the U.K. and Ireland. The downside risk is huge.

For example, business leaders in the U.K. expect the country's economy to get worse in 2012, according to a poll released Monday.  A recent Goldman Sachs survey forecast that the U.K.'s gross domestic product (GDP) will rise 0.7% this year, down from 0.9% in 2011.  
Tags: AMZNNFLX

The retailer sends mixed signals regarding the future of the e-reader.

By The Fiscal Times Jan 9, 2012 12:57PM
NookBy Suzanne McGee, The Fiscal Times

What on earth is Barnes & Noble (BKS) doing pondering the spin-off of the division that makes its Nook e-readers and tablets? It’s hard to find a way to "spin" that news into anything resembling an upbeat signal for either Barnes & Noble or its stock.

William Lynch, the bookseller’s CEO, dropped the possibility of a spin-off into a discussion of the company’s prospects last week, even as he revealed that year-end results are likely to fall short of investors’ hopes and analysts’ forecasts. 

Pipelines and processing plants put this MLP in the sweet spot as US gas production ramps up.

By TheStockAdvisors Jan 9, 2012 12:17PM
Image: Natural gas plant (© Kevin Burke/Corbis)This post is one in a series in which more than 50 newsletter advisers share their Top Picks for 2012.

By Amy Calistri, The Daily Paycheck

Enterprise Products Partners LP (EPD), a Houston-based master limited partnership (MLP), operates over 50,000 miles of gas, crude oil, natural gas liquids (NGL) and petrochemical pipelines. 
Tags: EDPEPD

Travelers is upgraded to 'conviction buy' at Goldman, while Akamai is downgraded to 'sell' at Citigroup.

By MSN Money Partner Jan 9, 2012 12:01PM
Information provided by Theflyonthewall.com

Monday's noteworthy upgrades include:
  • Broadcom (BRCM) upgraded to Buy from Hold at Deutsche Bank
  • Comcast (CMCSA) upgraded to Outperform from Neutral at Macquarie
  • Hartford Financial (HIG) upgraded to Buy from Neutral at Goldman
  • MetLife (MET) upgraded to Buy from Neutral at Goldman
  • Travelers (TRV) upgraded to Conviction Buy from Buy at Goldman
  • Akamai (AKAM) upgraded to Hold from Underperform at Jefferies
  • J.C. Penney (JCP) upgraded to Hold from Sell at Deutsche Bank
 

The company's generics business is poised to grow after it recorded revenue of nearly $10 billion in 2010.

By Trefis Jan 9, 2012 10:10AM
CorbisPfizer (PFE) is the world's biggest pharmaceutical company and operates in two main segments: biopharmaceutical and diversified.

Biopharmaceutical includes primary care, specialty care, established products, emerging markets and oncology units that focus on treatment and prevention of cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, respiratory diseases, urogenital conditions, cancer, eye disease and endocrine disorders, among others. Its diversified unit includes animal health, consumer health and nutritional products such as nutritional supplements and toddler formula products. 
Tags: PFE

Booming foreign interest in domestic reserves creates big opportunity.

By InvestorPlace Jan 9, 2012 9:56AM
Kevin Phillips/Digital Vision/age fotostockBy Aaron Levitt

The U.S. and Canada are sitting on one of the biggest energy booms ever. An oil and gas production renaissance is under way, thanks to improved hydraulic fracturing and advances in drilling techniques. Though not without controversy, shale formations like the Marcellus, Utica and Eagle Ford have become hotbeds of North American drilling activity because these advances have made it possible to extract the plethora of fossil fuels trapped between the rocks.


With billions of dollars in revenue at stake, these regions have witnessed a land grab not seen since the California Gold Rush of the 1800s. While the usual suspects like Exxon (XOM) are staking their claims, North America's shale interests are getting plenty of attention from overseas sources as well.

 

Positive action on new drugs by FDA in 2011 bodes well for biopharmaceuticals in 2012, and Celgene can offer long-term growth.

By Gene Marcial Jan 9, 2012 9:37AM
SuperStockIs the Food and Drug Administration becoming more of an ally than an obstacle to young biotech companies? Some analysts are starting to believe so. The FDA last year approved 30 new drugs, the highest yearly total since 2004, which industry watchers say represents very positive news for biotech companies.

 

"We see the FDA's modestly raised fiscal 2012 budget supporting continued improvement in the approval of new drugs on first review cycle," says Steven Silver, a biotech analyst at Standard & Poor's. The FDA's approval of new drugs in 2011 jumped 63% after an increase of about 50% in 2010, indicating a much-improved dedication by the FDA in supporting biotech and pharmaceutical companies in their quest for badly needed new drugs, Silver argues.

 
Tags: AMGNCELG

A recently launched oil and gas trust offers protected payouts and attractive yield.

By TheStockAdvisors Jan 8, 2012 6:03PM
Image: Oil Well Pumpjack © Roger Milley/Vetta/Getty ImagesThis post is one in a series in which more than 50 newsletter advisers share their Top Picks for 2012.

By Elliott Gue, The Energy Strategist

Chesapeake Granite Wash Trust (CHKR), the newest addition to the universe of U.S. oil and gas trusts, went public on Nov. 11.  It is also among the most promising and fastest-growing trusts in my coverage universe. 
Tags: CHKCHKR

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

STOCK SCOUTER

StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

111
111 rated 1
272
272 rated 2
474
474 rated 3
656
656 rated 4
638
638 rated 5
699
699 rated 6
623
623 rated 7
486
486 rated 8
260
260 rated 9
128
128 rated 10
12345678910

Top Picks

SYMBOLNAMERATING
DYNDYNEGY Inc10
TAT&T Inc9
VZVERIZON COMMUNICATIONS9
EXCEXELON CORPORATION8
AAPLAPPLE Inc10
More

Trending NOW

What’s this?

RECENT QUOTES

WATCHLIST

Symbol
Last
Change
Shares
Quotes delayed at least 15 min

ABOUT

Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.

MARKET UPDATE

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] S&P futures vs fair value: +5.70. Nasdaq futures vs fair value: +14.00. U.S. equity futures hover near their highs amid subdued action overseas. The S&P 500 futures trade six points above fair value. The benchmark index will enter the final session of the month with an August gain of 3.4%. Meanwhile, nine of ten economic sectors are on course to finish the month higher, while the smallest sector by weight-telecom services-will enter the session with an August decline ... More


Currencies

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.